Do Semaglutide and Tirzepatide Cause Muscle Loss?

Clinic patient education · Evidence checked 3 October 2026

Learn about Dr. Fowad Shahzad’s clinical focus and professional background.

Weight lost during semaglutide or tirzepatide treatment is not entirely body fat. Studies have also measured reductions in lean tissue. That deserves attention, but a scan reporting less lean mass does not, by itself, establish the same amount of skeletal muscle loss or a loss of strength. The practical aim is to improve health while protecting nutrition, strength and everyday function.

What does “lean mass” mean?

In the DXA studies discussed here, lean mass means soft tissue excluding fat and bone mineral. It includes skeletal muscle but is not a direct measurement of muscle alone. A body-composition result and a strength assessment answer different questions. Neither a lower scale weight nor a single scan can fully describe muscle health. SURMOUNT-1 body-composition study.

What did the semaglutide study find?

The exploratory STEP 1 DXA analysis included 140 participants without diabetes: 95 received semaglutide and 45 placebo. At 68 weeks, semaglutide participants’ total fat mass decreased by 19.3% and lean mass by 9.7% from their respective starting amounts. Lean tissue nevertheless represented a larger proportion of their remaining body weight. A 9.7% reduction in starting lean mass does not mean that 9.7% of the weight lost was muscle. STEP 1 investigators’ exploratory analysis.

What did the tirzepatide study find?

The SURMOUNT-1 DXA analysis included 160 participants with baseline and follow-up scans: 124 received pooled tirzepatide doses and 36 placebo. At 72 weeks, tirzepatide participants’ fat mass fell by 33.9% and lean mass by 10.9%. Approximately three-quarters of the weight lost was fat and one-quarter lean tissue. These describe different denominators: change in starting tissue mass versus the composition of weight lost. SURMOUNT-1 results.

Does semaglutide cause more muscle loss?

These separate studies cannot settle that question. They involved different participants, treatment durations, doses and analyses. Comparing their headline percentages is not a randomised comparison of the two drugs, and lean-tissue percentages cannot be relabelled as percentages of muscle destroyed.

SURMOUNT-5 did directly compare the medicines and found greater average weight reduction with tirzepatide over 72 weeks. Its headline weight and waist results do not establish which medicine better preserves muscle or strength. More weight loss and better muscle preservation are separate outcomes requiring separate evidence. SURMOUNT-5 trial report.

How can patients protect strength during treatment?

A joint advisory from four nutrition and obesity organisations recommends nutritional assessment, adequate protein intake and strength training alongside treatment. These are supportive strategies, not a guarantee that every patient will avoid lean-tissue loss. Discuss persistent nausea, difficulty eating enough, weakness or declining daily function with your clinician; the plan should fit your medical conditions and abilities. 2025 joint nutritional advisory.

Practical review questions include whether meals remain nutritionally adequate, whether activity is sustainable and whether ordinary tasks are becoming easier or harder. Avoid treating a faster fall on the scale as the only sign of success.

NIDDK advises muscle-strengthening activity on at least two days each week for adults, building up gradually. Exercises can use resistance bands, body weight or weights; the starting level should be appropriate for you. Seek guidance when pain, balance problems or health conditions affect exercise. NIDDK activity guidance.

Evidence checked: 3 October 2026. Educational information; individual assessment is needed. These studies do not verify the contents, quality or suitability of any locally supplied or imported product.

Discuss your treatment plan in Lahore

For an appointment with Dr. Fowad Shahzad, Zain and Wajid both arrange Lahore bookings from 08:00 to 23:00 Pakistan time. Confirm the consultation time, venue and fee before travelling; these are reception hours.

Call Zain: 0333 8288400 · WhatsApp Zain

Call Wajid: 0319 4631615 · WhatsApp Wajid

See all booking options and verified clinic locations. Johar Town consultations are by prior appointment, with Zain as the primary booking contact. Use reception messages for appointment arrangements; urgent symptoms need urgent medical care.

General information for adults, not an individual prescription or dosing plan. Suitability, contraindications and the complete information for the exact authorized product need review with your clinician.